quantikine human upar immunoassay elisa kit (R&D Systems)
Structured Review
Quantikine Human Upar Immunoassay Elisa Kit, supplied by R&D Systems, used in various techniques. Bioz Stars score: 94/100, based on 73 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/quantikine+human+upar+immunoassay/Human+uPAR+Quantikine+ELISA+Kit/pm38857636-242-10-16
Average 94 stars, based on 73 article reviews
Images
Related Articles
Concentration Assay:Article Title: Soluble Urokinase Receptor Levels in Secondary Focal Segmental Glomerulosclerosis Article Snippet: .. We detected the concentration of plasma and urinary suPAR using the Article Title: Patients With Combined Membranous Nephropathy and Focal Segmental Glomerulosclerosis Have Comparable Clinical and Autoantibody Profiles With Primary Membranous Nephropathy Article Snippet: .. The concentration of plasma and urinary suPAR was detected with Article Title: Primary and Recurrent Focal Segmental Glomerulosclerosis Closely Link to Serum Soluble Urokinase-type Plasminogen Activator Receptor Levels. Article Snippet: Background.. Serum soluble urokinase-type plasminogen activator receptor (suPAR) is implicated in the pathogenesis of native and recurrent focal segmental glomerulosclerosis (FSGS).. It is elevated in two-thirds of subjects with primary FSGS, but not in people with other glomerular diseases that can differentiate FSGS and other glomerular diseases. Article Title: MeSsAGe risk score: tool for renal biopsy decision in steroid-dependent nephrotic syndrome. Article Snippet: .. Plasma suPAR concentration was determined using Clinical Proteomics:Article Title: Soluble Urokinase Receptor Levels in Secondary Focal Segmental Glomerulosclerosis Article Snippet: .. We detected the concentration of plasma and urinary suPAR using the Article Title: Patients With Combined Membranous Nephropathy and Focal Segmental Glomerulosclerosis Have Comparable Clinical and Autoantibody Profiles With Primary Membranous Nephropathy Article Snippet: .. The concentration of plasma and urinary suPAR was detected with Article Title: Plasma Soluble Urokinase Receptor Level Is Correlated with Podocytes Damage in Patients with IgA Nephropathy Article Snippet: .. Plasma suPAR was quantified by the Article Title: MeSsAGe risk score: tool for renal biopsy decision in steroid-dependent nephrotic syndrome. Article Snippet: .. Plasma suPAR concentration was determined using Enzyme-linked Immunosorbent Assay:Article Title: Expression of Urokinase-type Plasminogen Activator Receptor and its Soluble Form in Type 2 Diabetic Kidney Disease. Article Snippet: Expression of Urokinase-type Plasminogen Activator Receptor and its Soluble Form in Type 2 Diabetic Kidney Disease Yujing Zhou,* Jianmin Ren,* Peng Li, Rong Ma, Mengkun Zhou, Ningxin Zhang, Xiangguo Kong, Zhao Hu, and Xiaoyan Xiao Department of Endocrinology, Qilu Hospital of Shandong University, Jinan, China Institute of Endocrinology and Metabolism, Shandong University, Jinan, China Key Laboratory of Endocrinology and Metabolism, Shandong Province in Medicine and Health, Jinan, China Department of Nuclear Medicine, Huashan Hospital, Fudan University, Shanghai, China Department of Nephrology, Yuhuangding Hospital Affiliated to Qingdao University, Yantai, China Department of Nephrology, Qilu Hospital of Shandong University, Jinan, China Article Title: Soluble Urokinase Plasminogen Activator Receptor as a Diagnostic and Prognostic Biomarker in Cardiac Disease Article Snippet: .. Two different kits are most commonly used, suPARnostic ® ELISA (Virogates) and other:Article Title: Soluble Urokinase Receptor and Chronic Kidney Disease Article Snippet: We then measured suPAR using a different assay (Quantikine Human uPAR Immunoassay [ |


